These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4657537)

  • 1. The effect of the analytical error on content uniformity sampling plans.
    Norberg R
    Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on eliminating the influence of random errors of analytical methods on the content uniformity test].
    Luo X; Wang X; Tao QF
    Yao Xue Xue Bao; 1989; 24(9):697-701. PubMed ID: 2618720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light induced fluorescence for predicting API content in tablets: sampling and error.
    Domike R; Ngai S; Cooney CL
    Int J Pharm; 2010 May; 391(1-2):13-20. PubMed ID: 20156535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of content uniformity test to tablet preparations.
    Kovács I; Hadady KK; Darbai MJ
    Pharmazie; 1980; 35(10):609-12. PubMed ID: 6779284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of content and uniformity of content of tablets prepared with a low concentration in active ingredient.
    Gayot A; Blouet E; Leterme P; Traisnel M
    Boll Chim Farm; 1988; 127(9-10):218-20. PubMed ID: 3248160
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of statistical analysis of blend and dosage unit content uniformity data obtained from the Product Quality Research Institute Blend Uniformity Working Group data-mining effort.
    Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Geoffroy JM; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N; Whiteman D;
    PDA J Pharm Sci Technol; 2004; 58(2):62-74. PubMed ID: 15113072
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of different laser irradiation methods for quantitative Raman tablet assessment.
    Johansson J; Pettersson S; Folestad S
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):510-6. PubMed ID: 15950422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the correction of systematic errors of analytical methods used in the content uniformity test].
    Guo XJ; He CF; Luo X; Wang X
    Yao Xue Xue Bao; 1992; 27(9):695-700. PubMed ID: 1293943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical controls for drug availability.
    Cook D
    Med Serv J Can; 1967 Mar; 23(3):323-36. PubMed ID: 6056376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on a new sampling scheme by variables for the content uniformity of tablets].
    Zhong DF; Wang X; Luo X
    Yao Xue Xue Bao; 1986 Feb; 21(2):130-6. PubMed ID: 3751592
    [No Abstract]   [Full Text] [Related]  

  • 12. Tablet splitting: much ado about nothing?
    Navarro RP
    J Manag Care Pharm; 2009 Apr; 15(3):272-4. PubMed ID: 19326958
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on flow properties of powders. IV. Flow properties of tablet granulations and the uniformity of tablet content.
    Kristensen HG
    Dan Tidsskr Farm; 1969; 43(9):213-9. PubMed ID: 5371697
    [No Abstract]   [Full Text] [Related]  

  • 14. The development of a blend-sampling technique to assess the uniformity of a powder mixture.
    Garcia TP; Wilkinson SJ; Scott JF
    Drug Dev Ind Pharm; 2001 Apr; 27(4):297-307. PubMed ID: 11411897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panel discussion: in process control and inspection for quality assurance. 3.
    Brofazi FR
    Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent applications of Chemical Imaging to pharmaceutical process monitoring and quality control.
    Gowen AA; O'Donnell CP; Cullen PJ; Bell SE
    Eur J Pharm Biopharm; 2008 May; 69(1):10-22. PubMed ID: 18164926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 19. Adequacy and verifiability of pharmaceutical mixtures and dose units by variographic analysis (Theory of Sampling) - A call for a regulatory paradigm shift.
    Esbensen KH; Román-Ospino AD; Sanchez A; Romañach RJ
    Int J Pharm; 2016 Feb; 499(1-2):156-174. PubMed ID: 26707245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A simple method for the determination of the degree of fineness of tablet fragments after disintegration].
    Sanders JC
    Pharm Weekbl; 1969 Jun; 104(24):485-92. PubMed ID: 5791767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.